https://www.selleckchem.com/pr....oducts/Camptothecine
06), and the incidence of severe neutropenia was 12.0% and 40.9%, respectively (p=0.05). The disease control rate and overall response rate of the AUC less then 20 mg*h/L group was lower than that of the ≥20 mg*h/L group 83.3% vs 97.1% (p=0.19) and 25.0% vs 51.4% (p = 0.1, respectively. Conclusions The 5-FU plasma concentration monitoring technique can improve the safety and efficacy of 5-FU administration to advanced colorectal cancer patients. It is expected to become an important means to individualise 5-FU use in the Chinese
Like
Comment
Share
